Elhan Webb | executive |
Richard Paulson | executive |
Reshma Rangwala | executive |
Sohanya Cheng | executive |
Michael Mason | executive |
Maurice Raycroft | analyst |
Colleen Hanley | analyst |
Brian Abrahams | analyst |
Matthew Cowper | analyst |
Good morning. My name is Carolyn, and I will be your conference operator today. At this time, I would like to welcome everyone to Karyopharm Therapeutics Second Quarter 2024 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.